PL4452267T3 - Pochodne 4-fenylo-tetrahydropirydyny do leczenia chorób słuchu - Google Patents
Pochodne 4-fenylo-tetrahydropirydyny do leczenia chorób słuchuInfo
- Publication number
- PL4452267T3 PL4452267T3 PL22844112.7T PL22844112T PL4452267T3 PL 4452267 T3 PL4452267 T3 PL 4452267T3 PL 22844112 T PL22844112 T PL 22844112T PL 4452267 T3 PL4452267 T3 PL 4452267T3
- Authority
- PL
- Poland
- Prior art keywords
- phenyl
- treating hearing
- tetrahydropyridine derivatives
- hearing diseases
- diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21306931 | 2021-12-23 | ||
| PCT/EP2022/087667 WO2023118544A1 (en) | 2021-12-23 | 2022-12-23 | 4-phenyl-tetrahydropyridine derivatives for treating hearing diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4452267T3 true PL4452267T3 (pl) | 2025-06-23 |
Family
ID=79831487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL22844112.7T PL4452267T3 (pl) | 2021-12-23 | 2022-12-23 | Pochodne 4-fenylo-tetrahydropirydyny do leczenia chorób słuchu |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20230390273A1 (pl) |
| EP (2) | EP4545066A3 (pl) |
| JP (1) | JP2024546180A (pl) |
| KR (1) | KR20240125025A (pl) |
| CN (1) | CN118715014A (pl) |
| AU (1) | AU2022419307A1 (pl) |
| CA (1) | CA3241657A1 (pl) |
| DK (1) | DK4452267T3 (pl) |
| ES (1) | ES3030316T3 (pl) |
| FI (1) | FI4452267T3 (pl) |
| HR (1) | HRP20250600T1 (pl) |
| HU (1) | HUE071387T2 (pl) |
| IL (1) | IL313499A (pl) |
| LT (1) | LT4452267T (pl) |
| MX (1) | MX2024007944A (pl) |
| PL (1) | PL4452267T3 (pl) |
| PT (1) | PT4452267T (pl) |
| SI (1) | SI4452267T1 (pl) |
| WO (1) | WO2023118544A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL4452267T3 (pl) * | 2021-12-23 | 2025-06-23 | Cilcare Dev | Pochodne 4-fenylo-tetrahydropirydyny do leczenia chorób słuchu |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2762514B1 (fr) | 1997-04-29 | 1999-10-22 | Sanofi Sa | Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation |
| JP2003527423A (ja) * | 2000-03-17 | 2003-09-16 | アルコン、インコーポレイテッド | 緑内障処置用の5−ht2および5−ht1aアゴニスト活性を有する化合物 |
| JP2010524844A (ja) * | 2007-04-26 | 2010-07-22 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 認知症のためのシンナミド化合物 |
| EP2278999B1 (en) * | 2008-04-21 | 2025-01-29 | Dompé farmaceutici S.p.A. | Auris formulations for treating otic diseases and conditions |
| EP3406259A1 (en) * | 2017-05-24 | 2018-11-28 | Dompé farmaceutici S.p.A. | Neurotrophins for use in the treatment of hearing loss |
| PL4452267T3 (pl) * | 2021-12-23 | 2025-06-23 | Cilcare Dev | Pochodne 4-fenylo-tetrahydropirydyny do leczenia chorób słuchu |
-
2022
- 2022-12-23 PL PL22844112.7T patent/PL4452267T3/pl unknown
- 2022-12-23 DK DK22844112.7T patent/DK4452267T3/da active
- 2022-12-23 MX MX2024007944A patent/MX2024007944A/es unknown
- 2022-12-23 HU HUE22844112A patent/HUE071387T2/hu unknown
- 2022-12-23 EP EP25163348.3A patent/EP4545066A3/en active Pending
- 2022-12-23 JP JP2024538335A patent/JP2024546180A/ja active Pending
- 2022-12-23 SI SI202230131T patent/SI4452267T1/sl unknown
- 2022-12-23 PT PT228441127T patent/PT4452267T/pt unknown
- 2022-12-23 WO PCT/EP2022/087667 patent/WO2023118544A1/en not_active Ceased
- 2022-12-23 ES ES22844112T patent/ES3030316T3/es active Active
- 2022-12-23 CN CN202280085786.4A patent/CN118715014A/zh active Pending
- 2022-12-23 CA CA3241657A patent/CA3241657A1/en active Pending
- 2022-12-23 LT LTEPPCT/EP2022/087667T patent/LT4452267T/lt unknown
- 2022-12-23 KR KR1020247024537A patent/KR20240125025A/ko active Pending
- 2022-12-23 EP EP22844112.7A patent/EP4452267B1/en active Active
- 2022-12-23 FI FIEP22844112.7T patent/FI4452267T3/fi active
- 2022-12-23 HR HRP20250600TT patent/HRP20250600T1/hr unknown
- 2022-12-23 AU AU2022419307A patent/AU2022419307A1/en active Pending
- 2022-12-23 IL IL313499A patent/IL313499A/en unknown
-
2023
- 2023-07-05 US US18/347,041 patent/US20230390273A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| LT4452267T (lt) | 2025-06-10 |
| DK4452267T3 (da) | 2025-05-26 |
| HUE071387T2 (hu) | 2025-08-28 |
| WO2023118544A1 (en) | 2023-06-29 |
| KR20240125025A (ko) | 2024-08-19 |
| CA3241657A1 (en) | 2023-06-29 |
| HRP20250600T1 (hr) | 2025-07-18 |
| EP4545066A2 (en) | 2025-04-30 |
| PT4452267T (pt) | 2025-05-16 |
| AU2022419307A1 (en) | 2024-06-27 |
| MX2024007944A (es) | 2024-09-10 |
| EP4545066A3 (en) | 2025-06-25 |
| CN118715014A (zh) | 2024-09-27 |
| EP4452267B1 (en) | 2025-04-23 |
| FI4452267T3 (fi) | 2025-06-03 |
| JP2024546180A (ja) | 2024-12-17 |
| EP4452267A1 (en) | 2024-10-30 |
| SI4452267T1 (sl) | 2025-07-31 |
| ES3030316T3 (en) | 2025-06-27 |
| US20230390273A1 (en) | 2023-12-07 |
| IL313499A (en) | 2024-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277333A (en) | Methods for treating eye diseases | |
| IL287168A (en) | Kit of pyrrolotriazine derivatives for the treatment of diseases mediated by pdgfra | |
| EP3759088B8 (en) | Triazine derivatives for treating diseases relating to neurotrophins | |
| SG11202108636SA (en) | Indazolyl-isoxazole derivatives for the treatment of diseases such as cancer | |
| PL4452267T3 (pl) | Pochodne 4-fenylo-tetrahydropirydyny do leczenia chorób słuchu | |
| IL290770A (en) | Compounds and methods for treating oxalate-related diseases | |
| SG11202110659SA (en) | Method for treating ocular diseases | |
| IL289436A (en) | Methods for treating eye diseases | |
| HK40112028A (en) | 4-phenyl-tetrahydropyridine derivatives for treating hearing diseases | |
| HK40081973A (en) | Combination treatment for fumarate-related diseases | |
| HK40110531A (en) | Methods for treating respiratory diseases | |
| AU2021903441A0 (en) | Methods for treating respiratory diseases | |
| AU2021901393A0 (en) | Treatment for alopecia | |
| HK40067840A (en) | Methods for treating ocular diseases | |
| HK40076432A (en) | Compounds and methods for treating oxalate-related diseases | |
| HK40095640A (en) | Treatment for schizophrenia | |
| AU2021901964A0 (en) | New treatment for neurodegenerative diseases | |
| GB202300613D0 (en) | Tobacco treatment | |
| GB202300605D0 (en) | Tobacco treatment | |
| PL4366727T3 (pl) | Nowe koncepcje terapeutyczne w leczeniu zapalenia ucha | |
| HK40100272A (en) | Methods for treating inflammatory skin conditions | |
| HK40112478A (en) | Treatment for inflammatory disease | |
| AU2023902197A0 (en) | Treatment for tinnitus | |
| AU2021901818A0 (en) | Methods for treating inflammatory skin conditions | |
| AU2020902218A0 (en) | New treatment for neurodegenerative diseases |